72.11.Z - Research and experimental development on biotechnology
58.14.Z - Publishing of journals and periodicals
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
73.1 - Advertising
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
85.59.B - Other out-of-school forms of education, not elsewhere classified
85.60 - Educational support activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -19,5 | -4,3 | 118,4 | 2859,9 |
EBITDA | -19,9 | -3,9 | 117,1 | 3075,1 |
Short time liabilities | 2,7 | 0 | 0 | 0 |
Equity capital | 144,1 | 139,8 | 258,2 | 84,7 |
Operating profit (EBIT) | -20,5 | -4,5 | 116,6 | 2683,3 |
Assets | 146,8 | 139,8 | 258,2 | 84,7 |
Net profit (loss) | -19,5 | -4,3 | 118,4 | 2859,9 |
Cash | 126,8 | 120,3 | 238,5 | 98,2 |
Net income from sale | 18,9 | 0 | 121,6 | -∞ |
Liabilities and provisions for liabilities | 2,7 | 0 | 0 | 0 |
Working assets | 126,8 | 120,3 | 239,3 | 98,9 |
Depreciation | 0,6 | 0,6 | 0,6 | 0 |
% | % | % | p.p. | |
Profitability of capital | -13,5 | -3,1 | 45,8 | 48,9 |
Equity capital to total assets | 98,2 | 100 | 100 | 0 |
Gross profit margin | -103,5 | 97,4 | 200,9 | |
EBITDA Margin | -105,8 | 96,4 | 202,2 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 53 | 0 | 0 | 0 |
Current financial liquidity indicator | 46.66975021362305 | 36,7 | ||
Net dept to EBITDA | 6.354887962341309 | 30.55769920349121 | -2.035856246948242 | -32,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane